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Evaluation of Growth-Promoting Systems for 
Heifer Calves Finished in the Feedlot
MGA feeding have not been fully ad-
dressed. Due to potential implant failure, 
and the possible additive effects of MGA 
in combination with an implant, produc-
ers may feed MGA plus implant cattle as 
primarily associated with heifers with 
functional, mature ovaries. The effects 
of implants on the development of the 
reproductive tract can vary. Character-
ization of implant effects on ovarian 
development are needed. Few studies 
provide data relevant to growth promot-
ing systems for heifers fed more then 150 
days, such as with heifer calves. Previous 
utilizing low dose (estrogenic) implants 
followed by high dose (estrogenic or 
estrogenic and androgenic) implants in 
long-fed steers and heifers. The objec-
tive of this study was to evaluate low 
dose/high dose implant systems when 
used in combination with the feeding 
the feedlot.
Procedure
Two-hundred ten head of pre-
dominantly British and British x Conti-
nental cross heifers were eartagged and 
vaccinated for seven-way clostridial, 
IBR, PI3, BRSV and H. Somnus. Heifers 
were fed a receiving diet for approxi-
mately 10 days, after which time they 
were assigned to blocks based on their 
average initial weight and randomly 
assigned to pens (seven head/pen). The 
initial weight was the average of weights 
taken on two consecutive days before 
feeding. Pens were randomly assigned 
to six implant treatment (Trt) groups 
heifers were weighed and implanted 
according to the treatment assignments; 
Synovex-C was implanted in groups 
1 through 3 and Synovex-H was im-
planted in groups 4 through 6. On day 
70, the heifers were implanted with 
Synovex-H and/or Finaplix-H, accord-
ing to the experimental design (Table 1). 
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Optimum growth-promotant 
include an initial implant with either
Synovex-C or Synovex-H, followed 
by replanting with Synovex-H and 
Finaplix-H.
Summary
-
nantly British and/or British x Conti-
nental cross heifers were assigned to six 
pens/treatment). In addition, melenges-
trol acetate (MGA) was provided to four 
treatment groups from day 28 until 48 
hours prior to slaughter. Heifers not fed 
MGA had the greatest number of imma-
ture ovaries, although they were also the 
feed to gain ratio). Heifers fed MGA and 
implanted with Finaplix were the least 
Introduction
Generally, a recommended implant-
reimplant program consists of an initial 
implant with estrogenic activity, fol-
lowed by a second implant exhibiting 
both estrogenic and androgenic effects 70 
to 100 days prior to slaughter. However, 
feeding melengestrol acetate (MGA) is 
another option for improving gain and 
estrogen/androgen combinations and 
Table 1. Experimental design.
Study Implant treatmentsa Replicates Animals assigned
Group Day 0 Day 70 MGA fedb (No. of pens) per pen
1 Synovex-C Synovex-H + Finaplix H  none 5 7
2 Synovex-C Synovex-H + Finaplix-H  yes 5 7
3 Synovex-C Finaplix-H yes 5 7
4 Synovex-h Synovex-H + Finaplix H  none 5 7
5 Synovex-H Synovex-H + Finaplix-H  yes 5 7
6 Synovex-H Finaplix-H yes 5 7
aSynovex-C contains 10 mg estradiol benzoate and 100 mg progesterone; Synovex-H contains 20 mg es-
tradiol benzoate and 200 mg testosterone propionate; Finaplix-H contains 200 mg trenbolone acetate.
bMelengestrol acetate (MGA) was provided to all heifers at   .45 mg/hd/day from day 28 to 48 hours 
prior to slaughter.
(Continued on next page)
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Melengestrol acetate (MGA) was pro-
vided to groups 2, 3, 5 and 6 at .4 to 
.45mg/hd/day from day 28 until it was 
withdrawn from the feed 48 hours prior 
to slaughter. The feeding of MGA was 
delayed until day 28 when cattle were 
on the highest energy diet, a common 
practice in feedlots where supplement 
formulations and levels fed are designed 
At the start of the trial, all heifers were 
ration and were on full-feed by day 28 
(Table 2). Heifers were fed Rumensin 
and Tylan throughout the 172 day feeding 
trial. Full-weights were taken on days 28, 
70, 126 and prior to slaughter (day 172). 
Ovarian data, hot carcass weight and 
liver abscesses were determined on day 
of slaughter. Marbling score, fat thick-
ness, percent kidney, pelvic and heart 
fat (KPH), yield grade, number of dark 
cutters and ribeye area were recorded 
following a 24-hour (minimum) chill. 
During the study, three heifers were 
removed due to death or health-related 
problems independent of treatment as-
signment and were not included in the 
statistical analysis.
Statistical analyses for this trial were 
conducted using the GLM procedures 
of SAS (1991). Preplanned contrast 
included initial implant (IMP; group 
1, 2, and 3 versus 4, 5 and 6); growth 
promotant regimen (GP; groups 1 and 4 
versus 2 and 5 versus 3 and 6) and IMP x 
GP interaction except for characteristics 
which were compared using chi-square 
Table 2. Diet Composition.
Diet number
Item 1 2 3 4 5A 5B 5C
Days fed 5 5 5 6 7 98 46
Diet, % DM 74.02 72.66 70.18 70.98 68.96 69.08 66.39
Ingredients, % diet DM
Corn silage — — — — — — 7.50
Alfalfa hay 37.60 25.70 15.77 7.19 — — —
Ground high-moisture ear corn 25.00 25.00 30.00 30.00 30.00 30.00 15.00
Ground high-moisture corn 17.42 22.61 24.31 28.18 31.63 30.59 34.34
Dry-rolled corn 17.42 22.61 24.31 28.18 31.62 30.58 34.33
Mineral-vitamin premixa 1.25 0.92 0.54 — — — —
Rumensin supplementb 1.31 1.31 — — — — —
Liquid supplementd — 1.85 3.04 4.42 4.72 4.72 4.72
Rumensin/Tylan supplementc — — 2.03 2.03 2.03 2.03 2.03
Control/MGA supplemente — — — — — 2.08 2.08
Content, DM basis
Crude protein, % 12.55 12.50 12.00 12.00 12.03 12.08 12.12
Neg, Mcal/cwt 52.00 56.00 59.00 62.00 64.64 64.24 64.17
Nem, Mcal/cwt 80.74 85.16 88.59 91.95 94.95 94.46 94.12
Calcium, % 0.73 0.74 0.69 0.66 0.60 0.64 0.65
Phosphorous, % 0.34 0.34 0.34 0.34 0.35 0.35 0.34
Potassium, % 0.91 0.84 0.75 0.70 0.63 0.64 0.67
Magnesium, % 0.20 0.18 0.17 0.15 0.14 0.14 0.15
Sulfur, % 0.19 0.18 0.17 0.16 0.15 0.15 0.15
Salt, % 0.25 0.30 0.30 0.28 0.30 0.30 0.30
aCorn based supplement containing on DM basis 19.85% salt, 14.21% Ca, 3.85% P, .21% K, .17% Mg, 
.27% S, .066 ppm Mn, .066 ppm Zn, .066 ppm Fe, .0066 ppm Cu, .002 ppm I, .00067 ppm Co, and 
237,254 IU vitamin A/kg.
bContained on DM basis 96.72% ground corn, 2.14 % molasses, 1.14 % Rumensin 60 (60g monensin/
lb).
cContained on DM basis 96.05% ground corn, 2.13 molasses, 1.14% Rumensin 60 and 0.68% Tylan 40 
(40g Tylosin/lb).
dContained on DM basis 50% CP, 47% NPN, 12.30% Ca, 6.3% salt, .79% P, 4.76% K, .15% Mg, .35% 
S, .0035% Zn, .0010% Fe, .0028% Mn, .0013% Cu, .0008% I, .0001% Co, 105,000 IU vitamin A/ kg, 
24,500 IU vitamin D and 35 IU vitamin E/kg.
eControl supplement contained on DM basis 36.51% ground corn, 30.62% soybean hulls, 19.96% wheat 
midds, 4.21% molasses, 5.61% limestone, and 3.10% soybean meal. MGA (melengestrol acetate 441 
mg/kg) was put in at .5% of control supplement formulation to make the MGA supplement.
test. For those, the model included IMP, 
GP and a comparison between initial 
implant groups that received only MGA 
(Treatments 2 and 3 versus Treatments 
5 and 6). In addition, contrasts were 
performed between treatment groups re-
ceiving MGA versus groups fed no MGA 
(Treatments 1 and 4 versus Treatments 
2, 3, 5 and 6) and between Synovex-H 
in combination with Finaplix versus Fi-
naplix alone (Treatments 3 and 6 versus 
1, 2, 4 and 5). Liver abscesses, ovarian 
data, percent dark cutters and quality 
grade were analyzed by the frequency 
procedure of SAS (1991) using the chi-
square option.
Results
The implantation of Synovex-H 
increased average daily gains and 
decreased feed required per unit of gain 
(Table 3). The addition of melengestrol 
acetate (MGA) to the diet at day 28 did 
gains or dry matter intake. No differ-
ences in dry matter intake were observed
among the growth-promotant treatments. 
Feed required per unit of gain was the 
least from zero to 70 days and over the 
entire trial for heifers not fed MGA. At 
feed conversion were heifers fed MGA 
and implanted with only Finaplix.
Heifers not fed MGA had the largest 
ribeye area, while heifers implanted with 
Finaplix only had the smallest ribeye area 
(Table 4). Lower yield grade was also 
observed for heifers not fed MGA. Heif-
ers initially implanted with Synovex-H 
showed an increased occurrence of liver 
abscesses. No differences in quality 
grade were found.
There was an unusually large inci-
dence of dark cutter carcasses. This could 
not be attributed to any one experimental 
treatment, but possibly was caused by 
factors, including weather. The two days 
prior to slaughter, for example, were 
abnormally hot and humid. In addition, 
heifers were held overnight at the packing 
plant prior to slaughter and were not fed 
MGA 48 hours prior to slaughter. Heifers 
were not segregated by treatment at the 
packing plant.
Ovarian data (Table 5) indicate 
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Table 3. Initial implant (IMP) and overall growth promotant regimen (GP) effects on animal performance and carcass characteristicsa.
Treatment (Trt) group
Feed additive: None MGA None MGA Contrast P-Values by treatment number
        GP
Implant (day 0): C C C H H H IMP (1 & 4 vs IMP
Implant ( day 70): H/F H/F F H/F H/F F (1 2 3 vs 2 & 5 vs by GP 1 & 4 vs 3 & 6 vs
Trt No.: 1 2 3 4 5 6 4 5 6) 3 & 6) Interaction 2 3 5&6 1 2 4 & 5
Total no. head (reps) 35(5) 34(5) 34(5) 35 (5) 34 (5) 35 (5)
Weight, lb
Initial 614 615 616 614 616 616 .98 .99 1.00 .94 .95
28 d 701 702 703 714 710 711 .66 .99 .99 .97 .98
70 d 850 844 843 873 860 863 .45 .95 .99 .75 .89
Final (172 d) 1165 1171 1146 1196 1177 1163 .59 .79 .95 .63 .51
b 1168 1160 1131 1185 1165 1148 .69 .67 .98 .49 .42
ADG, lb
0-28 d 3.10 3.11 3.11 3.56 3.35 3.39 .02 .81 .75 .530 .84
28-70 d 3.55 3.39 3.33 3.78 3.59 3.63 .07 .40 .94 .181 .46
0-70 d 3.37 3.28 3.24 3.69 3.49 3.53 .02 .44 .91 .210 .53
70-172 d live wt 3.09 3.20 2.98 3.17 3.10 2.92 .84 .24 .75 .476 .01
70-172 d adj wt 3.08 3.06 2.79 3.03 2.96 2.77 .59 .12 .95 .183 .05
0-172 d live wt 3.20 3.23 3.08 3.38 3.26 3.18 .26 .32 .78 .272 .15
0-172 d adj wt 3.20 3.15 2.98 3.30 3.17 3.08 .42 .16 .92 .128 .08
DMI, lb
0-28 d 18.28 19.07 18.31 19.11 18.89 18.92 .52 .89 .80 .88 .75
28-70 d 19.09 19.13 19.02 19.58 9.76 19.62 .37 .98 .99 .94 .91
0-70 d 18.77 19.11 18.74 19.39 19.41 19.34 .42 .95 .97 .91 .84
70-172 d adj wt 20.30 21.30 20.16 21.08 21.23 21.98 .36 .55 .76 .70 .49
0-172 d adj wt 19.68 20.41 19.59 20.40 20.49 20.31 .37 .73 .86 .78 .62
Feed/gain       
0-28 d 5.90 6.15 5.97 5.38 5.65 5.61 .03 .57 .94 .33 .91
28-70 d 5.37 5.67 5.73 5.19 5.52 5.42 .09 .08 .85 .03 .28
0-70 d 5.56cd 5.84d 5.80d 5.25c 5.56cd 5.48cd .01 .05 .98 .02 .39
70-172 d adj wt 6.37 6.38 6.60 6.48 6.61 6.95 .16 .18 .82 .22 .07
0-172 d adj wt 6.15c 6.49e 6.61e 6.20cd 6.45de 6.60e .96 .001 .89 .01 .01
aC = Synovex-C, H= Synovex-H, F = Finaplix-H, and MGA = Melengestrol acetate, fed from day 28 to 170.
bBased on hot carcass weight and 62% dress.
cdeMeans within a row with different superscripts differ (P < .05).
Table 4. Initial implant and overall growth promoting regimen (GP) effects on carcass characteristicsa.
Treatment (Trt) Group
Feed additive: None MGA None MGA Contrast P-Values by treatment number
         GP
Implant (day 0): C C C H H H IMP (1 & 4 vs IMP
Implant ( day 70): H/F H/F F H/F H/F F (1 2 3 vs 2 & 5 vs by GP 1 & 4 vs 3 & 6 vs 2&3 vs
Trt No.: 1 2 3 4 5 6 4 5 6) 3 & 6) Interaction 2 3 5&6 1 2 4 & 5 5&6
Hot carcass weight, lb 723.9 720.0 702.0 734.8 722.2 711.9 .70 .68 .99 .49 .42 —
Dressing percentage 62.13 61.43 61.15 61.42 61.37 61.22 .48 .34 .58 .17 .26 —
Fat thickness, in 0.38 0.40 0.45 0.33 0.47 0.39 .68 .05 .09 .02 .36 —
KPH, % 2.37 2.31 2.41 2.10 2.25 2.40 .14 .20 .34 .20 .09 —
Rib-eye area, in 13.01c 12.14b 11.90b 13.26c 12.28b 11.95b .53 .01 .95 .01 .01 —
Marbling scoree 506 520 514 495 532 512 .97 .24 .73 .15 .98 —
Quality gradef 18.20 18.32 18.36 18.00 18.58 18.40 .90 .39 .65 .85 .80 —
Yield grade 2.20c 2.38cd 2.52d 1.91b 2.24c 2.30cd .07 .02 .90 .01 .04 —
Liver abscesses, %g 0.00 0.00 5.71 5.71 2.86 14.29 .05 .04 — .34 .01 .15
Dark cutter, %g 40.00 52.38 43.81 42.86 38.09 45.71 .63 .87 — .60 .84 .45
Quality grade, %g
Prime (Pr) 0.0 2.9 0.0 0.0 0.0 0.0 .31 .36 — .47 .48 .31
Choice 54.3 58.8 61.8 57.1 64.7 57.1 .24 .60 — .50 .92 .42
Select 45.7 38.2 35.3 40.0 35.3 42.9 .47 .43 — .50 .92 .44
Standard (Std) 0.0 0.0 2.9 2.9 0.0 0.0 1.00 .59 — .63 .62 .31
Choice+Pr 54.3 61.7 61.8 67.1 64.7 57.1 . 27 .66 — .44 1.00 .45
Select+Std 45.7 38.2 38.2 42.9 35.3 42.9 .23 .48 — .44 1.00 .41
aC = Synovex-C, H = Synovex-H, F = Finaplix-H, and MGA = Melendgestrol acetate, fed from day 28 to 170.
b,c,dMeans within a row with different superscripts differ (P < .05).
e450 = Slight average, 550 = Small average, 650 = Modest average.
f17 = Select average, 18 = Select high, 19 = Choice low.
gP-values based on chi-square analysis.
(Continued on next page)
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Table 5. Effect of initial implant (IMP) and overall growth promoting regimen (GP) on ovary development and functiona,
Treatment (Trt) group
Feed additive: None MGA None MGA Chi-square (P-values) by treatment number
        GP
Implant (day 0): C C C H H H I MP (1 & 4 vs
Implant ( day 70): H/F H/F F H/F H/F F (1 2 3 vs 2 & 5 vs 1 & 4 vs 3 & 6 vs 2&3 vs
Trt No.: 1 2 3 4 5 6 4 5 6) 3 & 6) 2 3 5&6 1 2 4 & 5 5&6
Missing, % 0.0 0.0 0.0 2.9 0.0 0.0 .31 .35 .15 .48 —
Very immature,(<15mm),% 0.0 0.0 0.0 0.0 0.0 0.0 — — — — —
Immature, (15-20mm), % 5.7 0.0 0.0 5.7 5.9 0.0 .36 .08 .05 .08 .14
Mature, (>20mm, no follicle), % 28.6 35.3 17.6 34.3 38.2 20.6 .66 .41 .35 .02 .49
Mature (multiple follicle), % 5.7 2.9 0.0 2.9 2.9 5.9 .67 .83 .54 .79 .26
Mature (Corpus Luteum), % 0.0 0.0 0.0 0.0 0.0 0.0 — — — — —
aC= Synovex-C, H = Synovex-H, F = Finaplix-H, and MGA = Melengestrol acetate, fed from day 28 to 170.
implanting with Finaplix alone reduced 
the number of immature ovaries and 
number of mature ovaries with no fol-
licle, but increased the number of mature 
not fed MGA had the greatest number 
of immature ovaries. However, these 
conversion (lower feed to gain ratio).
Data suggest optimum growth 
promotant systems for heifer calves, 
managed under the above-mentioned 
conditions, includes an initial implant 
with either Synovex-C or Synovex-H, 
followed by reimplant with Synovex-H 
and Finaplix-H.
1Mari Lubberstedt, research technician, 
Terry Mader, professor, Animal Science and Jill 
Heemstra, former research technician, North-
east Research and Extension Center, Concord; and 
Kelly Lechtenberg, Consultant Midwest Veterinary 
Research, Oakland, Nebraska.
Implant Strategies on Performance and Carcass 
Characteristics of Finishing Steers
Rob Cooper
Todd Milton
Frank Prouty1
Synovex® C followed by 
Synovex® PlusTM resulted in a 
substantial improvement in feed 
implant of Synovex® PlusTM or a 
reimplant program with Synovex® 
S.
Summary
-
ducted to evaluate implant strategies 
on performance and carcass charac-
teristics of yearling steers. Implanting 
steers with Synovex® C initially and then 
reimplanting with Synovex® Plus  75 
days prior to slaughter improved feed 
of Synovex® Plus  or a reimplant 
program using Synovex® S. Carcass 
quality, as measured by the percentage 
USDA Choice carcasses and marbling 
scores, was unaffected by implant strat-
egy. However, implanting steers with 
Synovex® Plus  as a single implant 
or in a reimplant program increased 
carcass weight were increased without 
decreasing carcass merit.
Introduction
The use of growth-promoting im-
plants has been widely adapted by 
the cattle feeding industry. Managing 
implant strategies requires matching 
payout, animal performance and carcass 
merit. Several growth-promoting im-
plants varying in dosage and hormonal 
composition are available. Numerous 
in performance with a combination of 
trenbolone acetate and estradiol com-
pared to estradiol alone. However, the 
percentage of cattle grading Choice can 
be reduced with this combination. Re-
cently, experiments have demonstrated 
improved performance, and little change 
in carcass merit, when steers were im-
planted with a low-dose estrogen fol-
lowed by a combination of trenbolone 
acetate and estradiol, compared to a 
single combination implant administered 
at the beginning of the feeding period. 
In most of these experiments, Ralgro®
has been the initial source of low-dose 
estrogen. Because Synovex® C is simi-
lar in estrogenic activity to Ralgro®, it 
may be an effective source of low-dose 
estrogen as an initial implant in a reim-
